These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Assessment of adverse effects of drugs on bile formation and bile composition. Paumgartner G Pharmacol Ther B; 1979; 5(1-3):209-17. PubMed ID: 386366 [No Abstract] [Full Text] [Related]
63. Deoxycholic acid and the pathogenesis of gall stones. Marcus SN; Heaton KW Gut; 1988 Apr; 29(4):522-33. PubMed ID: 3286385 [No Abstract] [Full Text] [Related]
64. Biliary sludge: curiosity or culprit? Lee SP; Hayashi A; Kim YS Hepatology; 1994 Aug; 20(2):523-5. PubMed ID: 8045512 [No Abstract] [Full Text] [Related]
65. [Etiology and clinical presentation of cholesterol cholelithiasis]. Kajiyama G Nihon Naika Gakkai Zasshi; 2000 Sep; 89(9):1728-37. PubMed ID: 11051644 [No Abstract] [Full Text] [Related]
66. The metabolic disorder in cholesterol gall stone disease. Nutr Rev; 1978 Feb; 36(2):45-8. PubMed ID: 345158 [No Abstract] [Full Text] [Related]
67. Relative proportions of biliary cholesterol, phospholipid and bile salts in Indian patients with cholelithiasis. Tandon RK; Dass Gupta KK; Kapur BM; Lal K J Assoc Physicians India; 1978 Sep; 26(9):783-5. PubMed ID: 744756 [No Abstract] [Full Text] [Related]
68. [Dissolution of gallstones: reality and prospects]. Dederer IuM Klin Med (Mosk); 1980 May; 58(5):16-21. PubMed ID: 6991803 [No Abstract] [Full Text] [Related]